Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 4, 1999, Pages 563-573

  Vignola, Antonio M ^a,d   Chanez, Pascal ^b   Chiappara, Giuseppina ^a   Siena, Liboria ^a   Merendino, Anna ^a,c   Reina, Clotilde ^a   Gagliardo, Rosalia ^a   Profita, Mirella ^a   Bousquet, Jean ^b   Bonsignore, Giovanni ^a,c  

^a CNR   (Italy)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

^c UNIVERSITY OF PALERMO   (Italy)

^d Istituto di Fisiopatologia Respiratoria   (Italy)

Author keywords

Apoptosis; Asthma; Chronic bronchitis; Eosinophils

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MONOCLONAL ANTIBODY; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; ASTHMA; BRONCHUS BIOPSY; CELL SURVIVAL; CELL TYPE; CHRONIC BRONCHITIS; CHRONIC DISEASE; CLINICAL ARTICLE; DISEASE SEVERITY; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; PNEUMONIA; PRIORITY JOURNAL; STATISTICAL ANALYSIS; T LYMPHOCYTE;

EID: 0033060178     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70225-3     Document Type: Article

References (49)

1. 1. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
2. 2. Vignola AM, Campbell AM, Chanez P, et al. HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Respir Dis 1993;148:689-94.
3. 3. Haslett C, Savill JS, Whyte MK, Stern M, Dransfield I, Meagher LC. Granulocyte apoptosis and the control of inflammation. Philos Trans R Soc Lond B Biol Sci 1994;345:327-33.
4. 4. White E. Life, death, and the pursuit of apoptosis. Genes Dev 1996;10:1-15.
5. 5. Craig RW. The bcl-2 gene family. Semin Cancer Biol 1995;6:35-43.
6. 6. Kumar S. ICE-like proteases in apoptosis. Trends Biochem Sci 1995;20:198-202.
7. 7. Matsumoto K, Schleimer RP, Saito H, Iikura Y, Bochner BS. Induction of apoptosis in human cosinophils by anti-Fas antibody treatment in vitro. Blood 1995;86:1437-43.
8. 8. Behrmann I, Walczak H, Krammer PH. Structure of the human APO-1 gene. Eur J Immunol 1994;24:3057-62.
9. 9. Meikrantz W, Schlegel R. Apoptosis and the cell cycle. J Cell Biochem 1995;58:160-74.
10. 10. Lane DP. Cancer. p53, guardian of the genome. Nature 1992;358:15-6.
11. 11. Salmon M, Scheel-Toellner D, Huissoon AP, et al. Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest 1997;99:439-46.
12. 12. Salmon M, Pilling D, Borthwick NJ, Akbar AN. Inhibition of T-cell apoptosis - A mechanism for persistence in chronic inflammation. The Immunologist 1997;5/3:87-92.
13. 13. Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K. Direct demonstration of delayed cosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158:3902-8.
14. 14. Woolley KL, Gibson PG, Carty K, Wilson AJ, Twaddell SH, Woolley MJ. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med 1996;154:237-43.
15. 15. Walsh GM, Wardlaw AJ. Dexamethasone inhibits prolonged survival and autocrine granulocyte-macrophage colony-stimulating factor production by human eosinophils cultured on laminin or tissue fibronectin. J Allergy Clin Immunol 1997;100:208-15.
16. 16. Bratton DL, Hamid Q, Boguniewicz M, Doherty DE, Kailey JM, Leung DY. Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis. J Clin Invest 1995;95:211-8.
17. 17. Simon HU, Blaser K. Inhibition of programmed eosinophil death: A key pathogenic event for eosinophilia? Immunol Today 1995;16:53-5.
18. 18 Sousa AR, Poston RN, Lane SJ, Nakhosteen JA, Lee TH. Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am Rev Respir Dis 1993;147:1557-61.
19. 19. Vignola AM, Chanez P, Chiappara G, et al. Transforming growth factor-β expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997;156:591-9.
20. 20. Yousefi S, Green DR, Blaser K, Simon HU. Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proc Natl Acad Sci U S A 1994;91:10868-72.
21. 21. Zhang S, Mohammed Q, Burbidge A, Morland C, Roche W. Cell culture from bronchial subepithelial myofibroblasts enhance eosinophil survival in vitro. Eur Respir J 1996;9:1839-46.
22. 22. Stern M, Savill J, Haslett C. Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoplosis. Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response. Am J Pathol 1996;149:911-21.
23. 23. Aas k. Heterogeneity of bronchial asthma. Allergy 1981;36:3-10.
24. 24. Bousquet J, Chanez P, Chanal I, Michel FB. Comparison between RAST and Pharmacia CAP system: a new automated specific IgE assay. J Allergy Clin Immunol 1990;85:1039-43.
25. 25. Lacoste JY, Bousquet J, Chanez P, et al. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 1993;92:537-48.
26. 26. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis 1991;144:1202-18.
27. 27. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
28. 28. Tai PC, Spry CJ, Peterson C, Venge P, Olsson I. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature 1984;309:182-4.
29. 29. Poston RN, Chanez P, Lacoste JY, Litchfield T, Lee TH, Bousquet J. Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. Am Rev Respir Dis 1992;145:918-21.
30. 30. Tsujimoto Y, Croce CM. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci U S A 1986;83:5214-8.
31. 31. Shorrock K, Roberts P, Pringle JH, Lauder I. Demonstration of insulin and glucagon mRNA in routinely fixed and processed pancreatic tissue by in-situ hybridization. J Pathol 1991;165:105-10.
32. 32. Anderson GP. Resolution of chronic inflammation by therapeutic induction of apoptosis. Trends Pharmacol Sci 1996;17:438-42.
33. 33. Synek M, Beasley R, Frew AJ, et al. Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med 1996;154:224-30.
34. 34. Holgate ST. The 1992 Cournand Lecture. Asthma: past, present and future. Eur Respir J 1993;6:1507-20.
35. 35. Bochner BS, Undem BJ, Lichtenstein LM. Immunological aspects of allergic asthma. Annu Rev Immunol 1994;12:295-335.
36. 36. Walker C, Kaegi MK, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991;88:935-42.
37. 37. Broide DH, Gleich GJ, Cuomo AJ, et al. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol 1991;88:637-48.
38. 38. Laitinen LA, Laitinen A, Heino M, Haahtela T. Eosinophilic airway inflammation during exacerbation of asthma and its treatment with inhaled corticosteroid. Am Rev Respir Dis 1991;143:423-7.
39. 39. Chanez P, Bousquet J, Couret I, et al. Increased numbers of hypodense alveolar macrophages in patients with bronchial asthma. Am Rev Respir Dis 1991;144:923-30.
40. 40. Sgonc R, Wick G. Methods for the detection of apoptosis. Int Arch Allergy Immunol 1994;105:327-32.
41. 41. Jaattela M, Benedict M, Tewari M, Shayman JA, Dixit VM. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 1995;10:2297-305.
42. 42. Kinoshita T, Yokota T, Arai K, Miyajima A. Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells. Oncogene 1995;10:2207-12.
43. 43. Noguchi K, Nakajima M, Naito M, Tsuruo T. Inhibition by differentiation-inducing agents of wild-type p53-dependent apoptosis in HL-60 cells. Jpn J Cancer Res 1995;86:217-23.
44. 44. Yousefi S, Hoessli DC, Blaser K, Mills GB, Simon HU. Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils. J Exp Med 1996;183:1407-14.
45. 45. Iversen PO, Robinson D, Ying S, et al. The GM-CSF analogue E21R induces apoptosis of normal and activated eosinophils. Am J Respir Crit Care Med 1997;156:1628-32.
46. 46. Ying S, Meng Q, Taborda-Barata L, Kay AB. Association of apoptosis of neutrophils and eosinophils and their ingestion by macrophages with resolution of the allergen-induced cutaneous late-phase response in atopic human subjects. Proc Assoc Am Physicians 1997;109:42-50.
47. 47. Cory S. Regulation of lymphocyte survival by the bcl-2 gene family. Annu Rev Immunol 1995;13:513-43.
48. 48. Hawkins CJ, Vaux DL. Analysis of the role of bcl-2 in apoptosis. Immunol Rev 1994;142:127-39.
49. 49. Mercer WE, Shields MT, Lin D, Appella E, Ullrich SJ. Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression. Proc Natl Acad Sci U S A 1991;88:1958-62.